Population
In vitro models studying HIV-1 and HIV-2 Tat proteins
Comparison
Domain substitution between Tat1 and Tat2 vs Wild-type Tat1 and Tat2
Design
Preclinical
Authors
Loading...
Basic domain dictates Tat transactivation potency; leaves open its contribution to HIV-1/HIV-2 replication differences in vivo.
The basic domain of HIV-2 Tat contributes to its inefficient trans activation of the HIV-1 LTR, partially due to an adjacent acidic residue.
Subramanian et al. (1992) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: